A fluorescent probe as a lead compound for a selective a-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB

被引：0
|
作者：
Di Nanni, Adriana [1 ]
Saw, Ran Sing [1 ]
Battisti, Umberto [2 ]
Bowden, Gregory [3 ]
Pichler, Bernd [4 ]
Herfert, Kristina [1 ]
Herth, Matthias [5 ]
Maurer, Andreas
机构：
[1] Eberhard Karls Univ Tubingen, Tubingen, Germany
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Univ Michigan, Ann Arbor, MI USA
[4] Werner Siemens Imaging Ctr, Tubingen, Germany
[5] Univ Copenhagen, Copenhagen, Sweden
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2023年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-084
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [1] A Fluorescent Probe as a Lead Compound for a Selective α-Synuclein PET Tracer: Development of a Library of 2-Styrylbenzothiazoles and Biological Evaluation of [18F]PFSB and [18F]MFSB
    Di Nanni, Adriana
    Saw, Ran Sing
    Battisti, Umberto M.
    Bowden, Gregory D.
    Boeckermann, Adam
    Bjerregaard-Andersen, Kaare
    Pichler, Bernd J.
    Herfert, Kristina
    Herth, Matthias M.
    Maurer, Andreas
    ACS OMEGA, 2023, : 31450 - 31467
  • [2] Development and evaluation of [18F](-)FEPAQ as a VEGFR2 PET tracer
    Prabhakaran, Jaya
    Majo, Vattoly
    Simpson, Norman
    Kassir, Suham
    Polavarapu, Hanish
    Bruce, Jeffrey
    Canoll, Peter
    Arango, Victoria
    Mann, J. John
    Kumar, J. S. Dileep
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [3] Bridging the gaps in 18F PET tracer development
    Michael G. Campbell
    Joel Mercier
    Christophe Genicot
    Véronique Gouverneur
    Jacob M. Hooker
    Tobias Ritter
    Nature Chemistry, 2017, 9 : 1 - 3
  • [4] IN VITRO AND IN VIVO EVALUATION OF THE LAT1 PET TRACER 2-[18F]FELP IN COMPARISON TO [18F]FET AND [18F]FDG
    Verhoeven, J.
    Bolcaen, J.
    Kersemans, K.
    De Meulenaere, V.
    Deblaere, K.
    Kalala, J.
    Van den Broecke, C.
    Vanhove, C.
    Goethals, I.
    De Vos, F.
    NEURO-ONCOLOGY, 2017, 19 : 46 - 46
  • [5] Bridging the gaps in 18F PET tracer development
    Campbell, Michael G.
    Mercier, Joel
    Genicot, Christophe
    Gouverneur, Veronique
    Hooker, Jacob M.
    Ritter, Tobias
    NATURE CHEMISTRY, 2017, 9 (01) : 1 - 3
  • [6] Biological evaluation of 2′-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET
    Mitterhauser, M
    Wadsak, W
    Wabnegger, L
    Mien, LK
    Tögel, S
    Langer, O
    Sieghart, W
    Viernstein, H
    Kletter, K
    Dudczak, R
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (02) : 291 - 295
  • [7] Evaluation of a new PET hypoxia tracer, [18F]HIC101, in comparison with [18F]FMISO
    Nakata, Norihito
    Okumura, Yuki
    Nagata, Eriko
    Kiriu, Masato
    Hayashi, Akio
    Nishijima, Ken-ichi
    Zhao, Songji
    Tamaki, Nagara
    Kuge, Yuji
    Matsumoto, Hiroki
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [8] Development of [18F]ATPFU as a potential PET tracer for mTOR
    Kumar, J. S. Dileep
    Majo, Vattoly
    Simpson, Norman
    Prabhakaran, Jaya
    Mann, John
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [9] Evaluation of [18F]-CP18 as a PET Imaging Tracer for Apoptosis
    Su, Helen
    Chen, Gang
    Gangadharmath, Umesh
    Gomez, Luis F.
    Liang, Qianwa
    Mu, Fanrong
    Mocharla, Vani P.
    Szardenings, A. Katrin
    Walsh, Joseph C.
    Xia, Chun-Fang
    Yu, Chul
    Kolb, Hartmuth C.
    MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (06) : 739 - 747
  • [10] Preclinical evaluation of [18F]DiFA, a novel PET probe for tumor hypoxia, in comparison with [18F]MISO
    Yasui, Hironobu
    Zhao, Songji
    Higashikawa, Kei
    Ukon, Naoyuki
    Shimizu, Yoichi
    Matsumoto, Hiroki
    Tamaki, Nagara
    Kuge, Yuji
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345